Related Experiment Videos
[Alzheimer's disease and genes]
1Aarhus Universitet, Institut for Human Genetik. alj@humgen.aau.dk
Ugeskrift for Laeger
|October 27, 1997
Summary
Alzheimer's disease has two forms: rare early-onset caused by gene mutations and common late-onset influenced by the apolipoprotein E (APOE) E4 allele. APOE genotyping aids diagnosis but predictive testing for asymptomatic individuals is not recommended.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Context:
- Alzheimer's disease (AD) exhibits genetic heterogeneity, impacting both early-onset familial and late-onset sporadic forms.
- Familial AD is linked to dominant mutations in specific genes, with presenilin 1 (PS1) mutations being prevalent.
- Late-onset AD is multifactorial, with the apolipoprotein E (APOE) gene's E4 allele identified as a significant genetic risk factor.
Purpose:
- To delineate the genetic underpinnings of different Alzheimer's disease forms.
- To identify key genetic factors contributing to disease risk and presentation.
- To evaluate the utility of genetic testing in Alzheimer's disease diagnosis and prediction.
Summary:
- Rare, early-onset familial Alzheimer's disease results from dominant mutations in genes like PS1.
- The common, late-onset form of Alzheimer's disease is multifactorial, with the APOE E4 allele significantly increasing lifetime risk.
- Carriers of one or two copies of the APOE E4 allele show increased risk for late-onset Alzheimer's disease.
Impact:
- Understanding genetic heterogeneity is crucial for targeted research and potential therapeutic strategies.
- APOE genotyping can be a valuable adjunct in the diagnostic process for Alzheimer's disease.
- Predictive genetic testing for asymptomatic individuals is currently considered premature due to ethical and clinical considerations.